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Abstract
Pl-nectin is an ECM protein located on the apical surface of ectoderm cells of Paracentrotus lividus sea urchin embryo. Inhibition of
ECM–ectoderm cell interaction by the addition of McAb to Pl-nectin to the culture causes a dramatic impairment of skeletogenesis, offering
a good model for the study of factor(s) involved in skeleton elongation and patterning. We showed that skeleton deficiency was not due to
a reduction in the number of PMCs ingressing the blastocoel, but it was correlated with a reduction in the number of Pl-SM30-expressing
PMCs. Here, we provide evidence on the involvement of growth factor(s) in skeleton morphogenesis. Skeleton-defective embryos showed
a strong reduction in the levels of expression of Pl-univin, a growth factor of the TGF- superfamily, which was correlated with an
equivalent strong reduction in the levels of Pl-SM30. In contrast, expression levels of Pl-BMP5-7 remained low and constant in both
skeleton-defective and normal embryos. Microinjection of horse serum in the blastocoelic cavity of embryos cultured in the presence of the
antibody rescued skeleton development. Finally, we found that misexpression of univin is also sufficient to rescue defects in skeleton
elongation and SM30 expression caused by McAb to Pl-nectin, suggesting a key role for univin or closely related factor in sea urchin
skeleton morphogenesis.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Due to its relatively simple mode of development, the sea
urchin embryo offers a very useful model for the study of
commitment and differentiation of a single cell type and its
progeny. This is the case of larger daughters of the micro-
meres, appearing at 5th cleavage, which later in develop-
ment give rise to primary mesenchyme cells (PMCs) and
have been taken as an example of cell-autonomous specifi-
cation. PMCs are the only cells in the embryo that synthe-
size specific matrix proteins essential for the set-up of a
quite simple, although species-specific, skeleton. These ma-
trix proteins have been categorized as SM30, SM50, PM27,
msp130, etc., on the basis of their molecular weight (George
et al., 1991; Kitajima et al., 1996; Katoh-Fukui et al., 1991;
Harkey et al., 1995; Leaf et al., 1987; Killian and Wilt,
1996; Wilt, 1999; Illies et al., 2002). Each has been shown
to contribute to the elongation of different parts of the
skeleton (Guss and Ettensohn, 1997; Kitajima and Urakami,
2000) and to accumulate at different stages of embryo
development (Guss and Ettensohn, 1997). Despite the early
commitment of PMCs, whose fate does not depend on the
physical cell–cell interactions with other blastomeres of the
embryo (Okazaki, 1975), growing evidence suggests that
inductive signals from the ectoderm regulate both PMCs
positioning within the blastocoel and skeletal rod patterning
(Ettensohn and Malinda, 1993; Peterson and McClay, 2003;
Armstrong and McClay, 1994). These putative ectoderm-
derived signals may involve growth factors analogous to
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those present in horse serum (HS) or blastocoelic fluid
(BcF), which have been shown to be sufficient at least for in
vitro skeleton elongation (Okazaki, 1975; Kiyomoto and
Tsukahara, 1991; Page and Benson, 1992). Nevertheless,
the identification of putative growth factors involved in
skeletogenesis has remained elusive. A few transcription
factors have been identified that play a role in skeleton
development and may be upstream of ectoderm-derived
signals. Misregulation of ectodermal expression of SpMsx,
a member of the homeobox-containing genes involved in
the BMP pathway and known to be implicated in a variety
of epithelial–mesenchymal interactions in vertebrates, has
profound effects on the organization of primary and sec-
ondary mesenchyme cells within the blastocoel (Tan et al.,
1998). Similarly, spatially restricted expression of PlOtp, a
P. lividus homologue of the orthopedia homeobox-contain-
ing gene, has been shown to be involved in short range
signaling from the oral ectoderm to the underlying skeleto-
genic mesenchyme that is required for correct skeletal pat-
terning (Di Bernardo et al., 1999; Di Bernardo et al., 2000).
Our previous studies have demonstrated that, in the sea
urchin embryo, the appropriate contact of ectoderm cells
with Pl-nectin, an outer extracellular matrix (ECM) com-
ponent, is essential for correct morphogenesis of inner me-
soderm structures (Zito et al., 1998, 2000). Briefly, cultures
of early or mesenchyme blastulae grown in the presence of
monoclonal antibodies (McAb) to Pl-nectin contain em-
bryos with defects in the elongation and patterning of spi-
cule rods, although spicule nucleation (triradiate rudiments)
was not affected. Since we knew that Pl-nectin is apically
located on ectoderm and endoderm cells (Matranga et al.,
1992), the perturbation experiments suggested that ecto-
derm cells require contacts with Pl-nectin in order to send
inductive/permissive signals to PMCs needed for correct
skeletogenesis. Furthermore, since we found that in skele-
ton-deficient embryos ectoderm markers are expressed cor-
rectly, dorsoventral axis formation occurred normally and
endoderm differentiation and patterning were not affected
(Zito et al., 2000), we had an excellent model in which to
study specific inductive signals from ectoderm to skeleto-
genic mesenchyme.
In this paper, we extend our previous studies on sea
urchin embryo skeletogenesis and begin to address whether
growth factors are involved. Using our perturbation model
in which only skeleton elongation and patterning are spe-
cifically inhibited by McAb to Pl-nectin, we have examined
by RT-PCR and in situ hybridization the expression of two
growth factors, Pl-univin and Pl-BMP5-7, in relation to that
of the spicule matrix protein Pl-SM30. Expression of SM30
and univin, as well as spicule elongation, is strongly inhib-
ited by Pl-nectin McAb treatment of embryos. Interestingly,
misexpression of univin can rescue skeletogenesis in these
perturbed embryos, suggesting that this or some closely




Adult P. lividus sea urchins were collected along the
west Sicily coast. Eggs were fertilized and embryos were
cultured at a dilution of 4.000/ml in Millipore filtered sea
water (MFSW) containing antibiotics, at 16–18°C. Em-
bryos at different developmental stages were collected by
low-speed centrifugation.
Perturbation assay
Perturbation assays with McAb to Pl-nectin
(NEVIE11h7) on whole embryos were performed according
to Zito et al. (1998). Briefly, purified IgG was added at a
concentration of 1, 2, or 3 g/l to microtiter plate wells
containing 100 embryos/100 l. Embryos at the swimming
blastula (8 h after fertilization) or, alternatively, mesen-
chyme blastula (16 h after fertilization) were continuously
cultured in the presence of the antibody at 16°C.
Immunofluorescence
Immunofluorescence experiments were performed on
whole-mount embryos according to the method of Coffman
and McClay (1990), with some modifications (Zito et al.,
2000). Briefly, embryos were fixed for 2 min in ice-cold
0.1% formalin, permeabilized for 2 min in ice-cold MeOH,
and then rinsed in MFSW. Embryos were incubated with
wheat germ agglutinin–FITC conjugated (WGA-FITC;
SIGMA, 1:400 in MFSW) for 30 min on ice in the dark and
washed three times in MFSW. Embryos were observed
under a Zeiss Axioskop 2 Plus inverted microscope
equipped for epifluorescence.
Whole-mount in situ hybridization
Labeling of probes was performed as described by Gi-
anguzza et al. (1995), with some modifications. Briefly,
labeled single-stranded antisense and sense DNA probes
were generated by asymmetric PCR (Tautz et al., 1992) in
the presence of DIG-dUTP, utilizing an SM30 cDNA of 380
b as a template. Whole-mount in situ hybridizations were
performed as described by Di Bernardo et al. (1995), with
some modifications. All prehybridization and hybridization
steps were carried out in microtiter-plate wells, using
30–40 embryos per well. Fixed embryos were rehydrated,
digested with 150 g/ml Proteinase K (Sigma) for 20 min at
37°C, and hybridized with 20 ng/ml of DNA probe over-
night at 65°C. After hybridization, embryos were washed, in
several steps, in 5 SSC, 0.1% Tween 20, 2 SSC, 0.1%
Tween 20, 0.2 SSC, 0.1% Tween 20 at 45°C, and 0.2
SSC, 0.1% Tween 20 at r.t. After staining, embryos were
mounted on glass slides and observed under a Zeiss Ax-
ioscop 2 Plus inverted microscope. Hybridizations with
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sense probe were performed and showed no specific signal
above background.
Microinjection experiments
Sea urchin embryos were prepared for microinjection by
using a method modified by Cho (1999) for swimming
embryos. Briefly, embryos treated with McAb to Pl-nectin
were aligned in rows on 60-mm Petri dish lids precoated
with 1% agarose in MFSW. Microinjection needles from
Eppendorf were back-filled with a solution of 32% horse
serum (HS). The blastocoel of the embryos received approx-
imately 100 pl of the solution. Microinjection was per-
formed by using a Narishige IM-188 micromanipulator (Na-
rishige CO., LTD) and a Cell Tram Oil injector
(Eppendorf). Embryos were then collected with a mouth
pipette and allowed to develop in microtiter-plate wells at
16°C.
Isolation and identification of PCR amplification products
To study the relative levels of tissue-specific gene
expression in P. lividus embryo, homologues of univin,
BMP5-7, and SM30 were obtained from total RNA by
RT-PCR using specific primers designed on the basis of
the sequences for S. purpuratus (Stenzel et al., 1994;
Ponce et al., 1999) and P. lividus (Di Bernardo and
Spinelli, personal communication), respectively. In addi-
tion, we utilized an amplification product obtained with
specific primers designed on the basis of the reported
sequence for S24, a transcript encoding a ribosomal pro-
tein of the P. lividus embryo (Sgroi et al., 1996). This
amplification product was used as an internal reference control
in the following experiments. We obtained PCR products of
259, 117, 384, and 248 bp sizes by amplification with
univin, BMP5-7, SM30, and S24 primers, respectively,
which were cloned and sequenced. The sequences of
the primers used were: 5-ACTGGATCATCGCTCC-
GATG-3 and 5-CATCGGCATCCACAAGCTTC-3 for
univin; 5-TGGCAGGAATGGATCATCGC-3 and 5-
GAGTGTCTGCACGATGGCGTG-3 for BMP5-7; 5-TT-
GGGTTCAGTTGGAGAACC-3 and 5-GTTTCGTTGTCT-
TCGGGGTA-3 for SM30; and 5-CTGATCAGAC-
CATGCTCTAAGGT-3 and 5-CCTGATGTCGTCAGTA-
CAACGTA-3 for S24. The RT-PCR products will be referred
to as Pl-univin (NCBI Accession No. AJ302364), Pl-BMP5-7
(NCBI Accession No. AJ302363), Pl-SM30, and Pl-S24 in the
following.
RNA preparation and relative RT-PCR analysis
Total RNA was isolated by using a single-step method
(Chomczynski and Sacchi, 1987) from 100–500 embryos
treated with unrelated IgG or IgG to Pl-nectin. First-strand
cDNA was synthesized by using SuperScript reverse tran-
scriptase (Gibco, BRL) and random hexamers. An amount
of cDNA equivalent to 15 embryos was used for each
RT-PCR analysis. PCRs contained 0.8 M concentrations
of the appropriate primers, 0.2 mM dNTPs and 1.5 mM
MgCl2. PCR amplification conditions were as follows:
94°C, 30 s; 55°C, 45 s; 72°C, 30 s. Preliminary RT-PCR
experiments were performed to determine the linear range
of amplification for each set of primers (Fig. 3A). We
determined that saturation was not reached until after 40
cycles of amplification for each primer pair. Subsequent
PCR assays were then carried out for 40 cycles. One-fifth
volume of the PCR products was analyzed on a 3% agarose
gel. Densitometric analysis was performed by using a Bio-
Rad imaging system, and quantitation was performed by
using image analysis software (Molecular Analyst).
Preparation of synthetic mRNA for microinjection
For preparation of univin mRNA, a template containing
univin cDNA inserted into pSP64T at the BglII site was
used. Capped, polyadenylated mRNA was synthesized by
using the mMessage mMachine kit (Ambion). RNA was
purified according to the manufacturer’s instructions, resus-
pended in 30% glycerol filtered through 0.22-m filters
(Millipore). RNA concentrations and quality were analyzed
by spectrophotometry and electrophoresis through agarose
gels.
Egg injection and treatment with McAb to Pl-nectin
Eggs, dejellied in MFSW pH 4.5, were injected with
synthetic mRNA at the concentrations described in Results.
Only batches of eggs that gave rise to embryos with normal
development after injection of glycerol alone were utilized.
Twenty-four hours after microinjection, swimming embryos
were collected and part of them were cultured in the pres-
ence of McAb to Pl-nectin in microtiter-plate wells for the
following 24 h, at 16°C. Embryos were examined with a
Zeiss Axioscop 2 Plus inverted microscope.
RNA preparation from microinjected embryos and relative
RT-PCR analysis
PolyA RNA was isolated according to the manufactur-
er’s instructions using Dynabeads Oligo (dT)25 (Dynal Bio-
tech) from 15–20 embryos. Then, a single-step RT-PCR
was carried out using SuperScript One-Step RT-PCR kit
(Invitrogen) according to the manufacturer’s instructions.
The RT reaction was performed for 30 min at 45°C; after
denaturation for 5 min at 94°C, PCR amplification was
performed for 35 cycles as follows: 94°C, 30 s; 55°C, 45 s;
72°C, 30 s. Total volume of the PCR products was analyzed
on a 3% agarose gel stained with ethidium bromide.
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Results
PMC ingression and specific gene expression in normal
and perturbed embryos
We have previously shown that culture of early blastula
embryos in the presence of McAb to Pl-nectin greatly af-
fects both skeleton growth and patterning, but has no effects
on ectoderm and endoderm differentiation (Zito et al., 1998,
2000). Embryos were classified on an arbitrary scale where
the severity of skeleton deficiencies was evaluated from
types 1 to 4, type 1 (T1) being normal embryos, type 2 (T2)
and type 3 (T3) embryos with partial skeleton defects, and
type 4 (T4) embryos with the most dramatic skeleton de-
fects (Zito et al., 1998). In addition, we have recently
identified a fifth morphology, defined as type 5 (T5) em-
bryos, showing the presence of the triradiate spicule rudi-
ments as the sign of the initiation of spiculogenesis, but with
no further growth. Control embryos were cultured in the
presence of unrelated IgGs and did not show any apparent
defects when compared with embryos raised in normal sea
water.
In order to study the effects of skeleton impairment at the
levels of mRNA and protein expression, it was important to
obtain embryos with different degrees of skeleton defects on
a very reproducible basis. This was achieved by culturing
embryos continuously for 24 h with different concentrations
of McAb to Pl-nectin, and it is summarized in Fig. 1, where
different skeleton defective morphologies are shown. Using
low concentrations of McAb, corresponding to 1 g/l, we
observed about 90% of the embryos with weak (Fig. 1B and
G, T2) or intermediate (Fig. 1C and H, T3) skeleton defects.
In this case, embryos eventually recover skeleton develop-
ment 48 h after the treatment and approach the morphology
of control embryos (Fig 1. A and F, T1). Using medium
McAb concentrations, corresponding to 2 g/l, 90% of
embryos showed intermediate (Fig. 1C and H, T3) or strong
(Fig. 1D and I, T4) skeleton defects. However, even in this
case, embryos eventually developed a quite normal skeleton
48 h after the treatment. A complete inhibition of skeleton
development was obtained with high McAb concentrations,
corresponding to 3 g/l. In this case, about 90% of the
embryos exhibited T4 (Fig. 1D and I) and T5 (Fig. 1E and
J) morphologies and, what is more striking, they were
blocked in skeleton elongation and never developed a nor-
mal skeleton, even 48 h after the treatment. Concentrations
of McAb to Pl-nectin higher than 3 g/l were obviously
toxic, since they caused a general impairment of develop-
ment, and embryos eventually died within 24 h of culture.
One explanation for the perturbation effects observed is
that a reduced number of PMCs ingresses into the blasto-
coel. Alternatively, the skeleton defects observed could
have been the result of a reduction in the number of PMCs
expressing spicule-specific proteins necessary for the con-
struction of the skeleton. To compare the number of PMCs
in normal embryos and those treated with McAb to Pl-
nectin, we stained them with WGA-FITC. We found that,
although control embryos had a well-defined skeleton, typ-
ical of an early pluteus stage (Fig. 2A), and perturbed
embryos had a gastrula-like shape with short triradiate spi-
cule rudiments (Fig. 2B), the total number of ingressed
PMCs in T1 (Fig. 2C) and T4 (Fig. 2D) embryos did not
Fig. 1. Skeleton defects obtained after culturing embryos in the presence of different concentrations of McAb to Pl-nectin. (A, F) Type 1 embryo with normal
skeleton; (B, G) Type 2 and (C, H) type 3 embryos with partial skeleton defects; (D, I) Type 4 and (E, J) type 5 embryos with strong skeleton defects. High
concentrations of McAb to Pl-nectin (High) inhibit skeleton development (arrowhead); medium (Medium) and low (Low) concentrations of McAb to
Pl-nectin allow skeleton development (arrows). Control embryos were cultured in the presence of unrelated IgGs. Scale bar, 50 m.
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change. To determine whether in control and perturbed
embryos all PMCs were actively expressing skeleton-spe-
cific genes, we analyzed the expression of the SM30 gene,
which encodes a spicule matrix protein, that has already
been shown to be affected by external cues (Urry et al.,
2000). Hence, we performed in situ hybridization experi-
ments on whole-mount embryos coming from the same
perturbation experiment, by using a Pl-SM30 anti-sense
probe on control and perturbed embryos. As shown in Fig.
2, 32 out of 36 PMCs present in T1 (control) embryos
express Pl-SM30 (Fig. 2E), whereas in T4 embryos, many
fewer of the ingressed PMCs were positive (Fig. 2F). Hy-
bridizations with sense probe showed no specific signal
above background (not shown). The embryos shown in Fig.
2E and F are representative examples of 4 experiments that
were scored and used for a statistical analysis of in situ
hybridization. In conclusion, we found that Pl-SM30 tran-
script was detected in 14  7 PMCs in T4 (perturbed)
embryos, while 32  7 PMCs were positive in T1 (control)
embryos, indicating about a 43% reduction in the number of
PMCs actively expressing the Pl-SM30 gene.
Microinjection of horse serum rescues skeleton-defective
embryos
In vitro cultures of PMCs in the presence of HS or BcF
have shown the elongation of spicules and therefore indi-
cated the need for some kind of signals coming from the
environmental medium (Okazaki, 1975; Harkey and
Whitely, 1980; Kiyomoto and Tsukahara, 1991). We hy-
pothesized that skeleton deficiencies found in embryos cul-
tured in the presence of McAb were caused by the insuffi-
ciency or lack of putative growth factor(s). If this hypothesis
is correct, then microinjection of HS into the blastocoelic
cavity of perturbed embryos would lead to the partial or
total recovery of skeleton deficiencies caused by McAb to
Pl-nectin. To test this assumption, we performed prelimi-
nary experiments in which very early blastula embryos (6 h
after fertilization) were first injected with different concen-
trations of HS, namely 8, 32, and 64%, and then cultured in
the presence of McAb to Pl-nectin for 42–48 h. We found
that any of the HS concentrations used for microinjection
were able to rescue skeleton deficient embryos, as indicated
by the remarkable increase in the number of T2 and T3
embryos, reaching about 90% of the total (not shown). To
further demonstrate that HS is sufficient to rescue perturbed
embryos, we designed another experimental procedure as
follows: first, we cultured embryos in the presence of McAb
to Pl-nectin for different lengths of time (3, 6, and 22 h), and
then we microinjected them with 100 pl 32% HS. This
concentration of HS was adopted for two reasons: first, to be
sure to have a moderate excess of growth factor available in
the blastocoel, and second, because considering the volume
of injected blastocoel equal to 523 pl, this concentration
would give a 6% HS theoretical final concentration in the
blastocoel. This value is very close to the 4% HS concen-
tration used for in vitro experiments of spicule growth using
isolated PMCs (Okazaki, 1975; Harkey and Whitely, 1980).
As control embryos, we took those that were cultured for the
same period of time in the presence of McAb to Pl-nectin,
but never received the microinjection of HS. Results are
summarized in Table 1. In a first series of experiments, we
asked if HS could rescue embryos cultured for a short time
in the presence of McAb to Pl-nectin. Mesenchyme blastula
embryos (16–17 h postfertilization) were cultured for either
3 or 6 h (trials 1 and 2, respectively) in the presence of
McAb to Pl-nectin before HS microinjection. Controls, with
no HS microinjection, were skeleton-defective and showed
between 90 and 80% of T4 and T5 morphologies, respec-
tively. In contrast, microinjection of HS rescued skeleton
development with percentages of T2–T3 embryos between
60 and 68% in one case (3 h) and between 87.5 and 100%
for the other (6 h). In a second series of experiments, we
asked if HS microinjection could rescue skeleton develop-
Fig. 2. Number of PMCs and specific gene expression in perturbed em-
bryos. (A, B) brightfield micrographs of type 1 and type 4 embryos,
respectively. (C, D) Direct immunofluorescence with WGA-FITC of type
1 and type 4 embryos, respectively. (E, F) In situ hybridization analysis
with the Pl-SM30 antisense probe of type 1 and type 4 embryos, respec-
tively. Scale bar, 50 m.
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ment even after longer periods of culture in the presence of
the antibody. Early blastula embryos (6 h postfertilization)
were cultured for 22 h in the presence of high concentra-
tions of antibody to obtain T4 embryos before HS micro-
injection. In the bottom panel of Table 1 (Trial 3) are results
of a representative experiment showing that all the embryos
that received HS microinjection, observed 24 h later, re-
gained skeleton development (100% T2–T3); conversely,
we found that uninjected control embryos had 100% of
inhibition (T4–T5). In particular, we found that in unin-
jected control embryos, all PMCs ingressed the blastocoel,
ventrolateral clusters were formed and started to make trira-
diate spicules that didn’t continue to elongate, supporting a
specific role for HS in spicule elongation.
Expression of univin, BMP5-7, and SM30 in normal and
skeleton-defective embryos
Since we found that microinjection of HS, which is a
rich source of growth factors, resulted in the recovery of
spicule growth in perturbed embryos, and since skeleto-
genesis in other systems is known to depend heavily on
members of the BMP family (Wozney et al., 1988), we
decided to analyze the expression of two genes encoding
such factors as well as that of a gene coding for a spicule
matrix protein (SM30), which is active during the spicule
elongation phase of skeletogenesis (Guss and Ettensohn,
1997; Kitajima and Urakami, 2000). The two candidates
selected were univin and BMP5-7, whose gene sequences
from the S. purpuratus sea urchin embryo have been
reported (Stenzel et al., 1994; Ponce et al., 1999). In our
experiments, expression of univin and BMP5-7 was mon-
itored during normal and perturbed spiculogenesis, with
the aim of finding a correlation between their gene ex-
pression levels and skeleton abnormalities. At first, we
carried out a stage-dependent analysis of the two BMPs
members and SM30 on control embryos from mesen-
chyme blastula to pluteus stages. Amplification product
band intensities were measured by a densitometric image
scanning analyzer as shown in Fig. 3B and C. Values
were normalized to the Pl-S24 values. We found a stage-
dependent change in the transcript levels of Pl-univin and
Pl-SM30. Specifically, Pl-univin and Pl-SM30 transcript
levels increased from the beginning of gastrulation
through the late pluteus stage, coinciding with the time of
spicule elongation. The concentration of both Pl-univin
and Pl-SM30 transcripts decreased at 44 h of develop-
ment when skeletogenesis was almost complete. In con-
trast, Pl-BMP5-7 transcript levels were almost constant
and low from the mesenchyme blastula to the early plu-
teus stage, increasing only after 48 h of development.
The parallel expression of Pl-univin and Pl-SM30 sug-
gested a possible involvement of Pl-univin and not Pl-
BMP5-7 during skeletogenesis. In order to investigate this
hypothesis, we monitored by RT-PCR assay the expression
of Pl-univin, Pl-BMP5-7, and Pl-SM30 transcripts in em-
Fig. 3. Relative RT-PCR analysis of the levels of Pl-univin, Pl-BMP5-7,
and Pl-SM30 transcripts during development. (A) Validation of the
assay: RT-PCRs were carried out for 30, 35, 40, and 45 cycles for each
set of primers as indicated. Amplification products were loaded on the
same agarose gel and bands visualized by ethidium bromide. (B) Elec-
trophoretic analysis of RT-PCR products obtained for each set of
primers with cDNA from different stages. (C) Histogram showing the
quantitation of RT-PCR products from the gel shown in (B). Values,
obtained from measurement of band intensities for each amplification
product, were normalized to the Pl-S24 values. Maximal values were
normalized to developmental stages with the highest levels of expres-
sion of a particular mRNA. Stages: mB1, mesenchyme blastula; MG,
middle gastrula; LG, late gastrula; Pl, pluteus larva. Hour: hours from
fertilization.
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bryos with strong skeleton defects, cultured in the presence
of the antibody for 24 h, and harvested 42 h after fertiliza-
tion. Values obtained from measurement of band intensities
for each amplification product were normalized to the Pl-
S24 values, which were assumed to be unaffected by treat-
ment with McAb to Pl-nectin. Fig. 4 shows the ethidium
bromide stained gel of a representative RT-PCR experiment
and a quantitative analysis of five different experiments.
Pl-univin expression is strongly reduced in perturbed em-
bryos with strong skeleton defects with respect to control
embryos. Similarly, Pl-SM30 expression is reduced in per-
turbed embryos (T4 and T5 morphologies). It should be
noted that about the same average decrease is found when
measuring gene expression by RT-PCR (2-fold) and the
number of SM30-positive cells by in situ hybridization
(43%) (see Fig. 2). On the contrary, the levels of expression
of Pl-BMP5-7 remained low and constant regardless of the
skeleton fate and did not differ between control and per-
turbed embryos.
Microinjection of univin mRNA prevents embryos from
skeleton defects and rescues perturbed embryos
Differential expression of univin in control and perturbed
embryos suggests that it is involved in skeletal growth.
Interestingly, it was already shown by in situ experiments
that univin mRNA is accumulated in progressively re-
stricted areas outlining a circumequatorial band for stages
between cleavage and gastrula, and at the growing arms at
the pluteus stage (Stenzel et al., 1994), i.e., at times and
places consistent with a role in promoting skeletogenesis.
To show direct evidence of univin involvement in skeleto-
genesis, we asked whether injection of mRNA encoding
full-length S. purpuratus univin could reverse the skeleton
defects caused by treatment with the McAb to Pl-nectin.
Synthetic, capped, polyadenylated mRNA was injected into
sea urchin eggs and, about 20–27 h after fertilization, em-
bryos were cultured in high antibody concentrations for
about 24 h before microscopic investigation. We found that,
about 20 h after fertilization, before the addition of the
antibody, univin mRNA-injected embryos and glycerol-in-
jected controls were indistinguishable as they both reached
the mesenchyme blastula stage (not shown). When devel-
opment was monitored 24 h after culture in the presence of
the antibody, a noteworthy difference among cultures was
observed: while glycerol-injected control embryos were at
the pluteus stage (Fig. 5A), glycerol-injected embryos cul-
tured in the presence of McAb to Pl-nectin showed the
typical T4 morphology, with an undeveloped skeleton and
no arms (Fig. 5B). On the contrary, embryos injected with
univin mRNA, although cultured for 24 h in the presence of
McAb to Pl-nectin, were partially rescued in their skeleton
development as assessed by the typical T2–T3 morphology
(Fig. 5C and D). In Table 2 are collected data coming from
different experiments in which embryos, microinjected with
Table 1












1a 16 — 90 (27/30) 10 (3/30)
1b 16 3 32 (7/22) 68 (15/22)
1c 16 6 40 (9/23) 60 (14/23)
2a 17 — 81 (42/52) 19 (10/52)
2b 17 6 0 100 (7/7)
2c 17 6 12.5 (1/8) 87.5 (7/8)
3a 6 — 100 (6/6) 0
3b 6 22 0 100 (4/4)
(), no HS injection.
Fig. 4. Relative RT-PCR analysis of the levels of Pl-SM30, Pl-univin, and Pl-BMP5-7 transcripts in control (McAb ) and perturbed embryos (McAb ).
A representative ethidium bromide stained gel is shown in the upper panel. Histogram shows the quantitative analysis of five different experiments, for which
the SD has been calculated. Values obtained from measurement of band intensities for each amplification product were normalized to the Pl-S24 values and
are expressed in arbitrary units.
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different concentrations of univin mRNA, were monitored
for rescue of skeleton development. Significance was deter-
mined according to the Student’s t test (P  0.05), by
pooling the numbers of the two groups of perturbed un-
injected and injected embryos, regardless of univin mRNA
dose. The number of rescued embryos increased when
higher concentrations of univin mRNA were injected, sug-
gesting a dose-response effect. No aberrations in skeleton
development were observed when embryos were microin-
jected with univin mRNA and allowed to develop without
McAb addition (not shown). In addition to the morpholog-
ical criteria used for the assessment of developmental re-
covery of skeleton elongation, a molecular analysis of the
expression of Pl-SM30 transcripts was performed by RT-
PCR on control, perturbed, and rescued embryos. Fig. 5E
shows the results of a representative experiment, in which
Pl-S24 expression is also shown. As predicted, Pl-SM30
mRNA levels are significantly increased in skeleton recov-
ering embryos, indicating that univin mRNA injection res-
cues the expression of Pl-SM30.
Discussion
In this report, we show that perturbation of skeleton
development in sea urchin embryos by interfering with
interactions of ectoderm cells with Pl-nectin in the ECM
results in reduced levels of Pl-univin expression, parallel to
reduced levels of Pl-SM30 expression. Moreover, we dem-
onstrate that misexpression of univin rescues these embryo
defects, promoting skeletal growth. These observations sup-
port the conclusion that the sea urchin Pl-univin gene is
involved in the ectoderm–mesoderm induction that regu-
lates skeletogenesis.
In our previous papers, we showed that skeleton defects
observed after treatment with McAb to Pl-nectin are not
caused by a direct action of McAb on PMCs. Instead, they
probably depend on a loss of the interaction between ecto-
derm cells and Pl-nectin, indirectly causing a loss of the
signal from ectodermal cells to the PMCs (Zito et al., 1998,
2000). The primary observations that support this conclu-
sion are that skeletal growth arrest occurs when the McAb
is added outside the embryo and not when it is injected into
the blastocoel where the PMCs reside (Zito et al., 1998).
This hypothesis is consistent with the finding that, although
PMCs are rigidly specified early in development to differ-
entiate as skeletogenic cells (Okazaki, 1975), skeleton mor-
phogenesis is governed by ectoderm-to-PMC interactions
(Armstrong et al., 1993; Guss and Ettensohn, 1997). Dif-
fusible growth factors have been suggested to mediate the
ectoderm–mesoderm induction. Until now, three members
of the TGF family have been identified in the sea urchin
embryo: univin (Stenzel et al., 1994), BMP5-7 (Ponce et al.,
1999), and LvBMP2-4 (Angerer et al., 2000). Among these,
univin is a good candidate to act as diffusible growth factor
since, according to its known reported sequence, it shows
features typical of a secreted protein (Stenzel at al., 1994).
Furthermore, univin gene expression has been shown to
become progressively restricted to areas outlining a cir-
cumequatorial band for stages between cleavage and gas-
trula, and in the growing arms at the pluteus stage in S.
purpuratus (Stenzel at al., 1994), i.e., at times and places
Table 2







 0 (0/8) 100 (8/8)
0.8 5 (1/19) 95 (18/19)
 0 (0/8) 100 (8/8)
0.8 21 (5/23) 78 (18/23)
 0 (0/7) 100 (7/7)
0.8 66 (4/6) 33 (2/6)
 0 (0/20) 100 (20/20)
1.2 50 (15/30) 50 (15/30)
 48 (27/56) 52 (29/56)
1.2 74 (29/39) 26 (10/39)
(), 30% glycerol injected
Fig. 5. Rescue of skeleton development after injection of univin mRNA.
Glycerol (control; A, B) or synthetic univin mRNA (C, D) was injected into
eggs of P. lividus, which were fertilized and, after 20 h of development,
were cultured for other 24 h in the absence (A) or in the presence (B, C, D)
of McAb to Pl-nectin. Scale bar, 50 m. (E) Relative RT-PCR analysis of
Pl-SM30 and Pl-S24 levels of control, perturbed, and rescued embryos.
Shown is a representative ethidium bromide gel of three different
experiments.
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consistent with a role in promoting skeletogenesis. BMP5-7
was also taken into consideration in the present study be-
cause of its homology to some BMPs, which, in other
systems, have been shown to have an osteoinductive activ-
ity (review in Hogan, 1996). We considered BMP2/4 a less
likely candidate for promoting skeletal growth based on its
temporal and spatial patterns of expression and its demon-
strated role in aboral ectoderm differentiation (Angerer et
al., 2000).
Defects in skeleton elongation and patterning do not
depend on the number of ingressed PMCs
First, we asked whether skeleton defects observed in
treated embryos were caused by a reduction in the total
number of PMCs. We found no significant changes in the
number of PMCs ingressed into the blastocoelic cavity and
also in their localization and arrangement in embryos with
strong skeletal defects. We have previously shown that the
first sign of perturbed development of the skeleton was
observed at later stages, when in control embryos triradiate
spicule rudiments elongated and branched, giving rise to the
various skeletal rods. In the most severe phenotypes, we
could observe only a slight elongation of the triradiate
spicules, correctly positioned in the ventrolateral side of the
blastocoel. In moderately perturbed embryos, these spicules
eventually branched to give rise to short body rods and anal
rods, with roughly undeveloped anterolateral rods (Zito et
al., 2000). These results indicate that the defects in skeleton
elongation and patterning do not depend on the number of
ingressed PMCs, but instead result from failure of PMCs to
deposit skeletal material. Altered skeletal growth has also
been observed in embryos treated with NiCl2, which have
the normal number of PMCs, but produce as many as a
dozen small triradiate skeletal spicules (Hardin et al., 1992).
There are other evidences that skeletal growth is regulated
and not autonomously specified in the PMCs. For example,
embryos with supernumerary PMCs, as many as two to
three times the normal number, produce normal skeletons
with no changes in their mass or pattern even with the extra
PMCs (Ettensohn, 1990). Moreover, in half- and quarter-
sized dwarf larvae, PMCs produced skeletons with a normal
pattern, although reduced in size (Takahashi and Okazaki,
1979). Taken all together, these findings indicate that elon-
gation and patterning of the skeleton are regulative events
and signaling pathways are required.
Microenvironmental cues are essential for skeleton
development
The defects in skeleton elongation and patterning can be
reversed by microinjection of HS, the same medium that
promotes skeletal growth in in vitro cultures of micromeres
or PMCs (Okazaki, 1975; Page and Benson, 1992). Al-
though the fundamental factor(s) has not yet been identified,
it is likely to be a growth factor(s) since HS contains many
such proteins. In addition, we found that, although the
PMCs from McAb-treated embryos do not produce elon-
gated spicules, they retain competence to do so. Recently,
we have demonstrated that PMCs transplanted from skele-
ton-defective embryos are still able to position themselves
at ventrolateral clusters and to synthesize skeleton if intro-
duced into the blastocoelic cavity of normal PMCs-deprived
embryos (Kiyomoto et al., submitted). The competence of
PMCs to respond to environmental signals lasts for consid-
erable periods of time if compared with their normal time
schedule of skeleton development. These results support the
hypothesis that the signal is reduced or absent in the blas-
tocoel of embryos treated with McAb to Pl-nectin. When it
is supplied, the PMCs resume the skeletogenic program.
Evidence that it is cells other than PMCs that supply the
signal comes from several studies. PMCs from full-size
donor embryos form a skeleton with an appropriately re-
duced size when transplanted into a dwarf host (Armstrong
and McClay, 1994). In agreement, PMCs from NiCl2-
treated embryos, in which they have a radialized distribu-
tion, form normal bilateral clusters when transplanted into
normal PMC-deprived hosts. On the contrary, normal PMCs
transplanted into radialized PMC-deprived hosts produce
radialized skeleton (Armstrong at el., 1993). In addition,
Ettensohn and Malinda (1993) have shown that, if ectoderm
from the tip of pluteus arms is microsurgically ablated,
spicule growth is considerably reduced. In conclusion, skel-
eton elongation greatly depends on the microenvironment in
which PMCs live, when the right cues are provided.
Cell–ECM interaction is required for SM30 and univin
gene expression
The interest in monitoring the expression of SM30, a
specific spicule matrix protein, in skeleton-defective em-
bryos came from findings reporting that the expression of
this gene is responsive to external cues (Urry et al., 2000)
and occurs during spicule elongation (George et al., 1991).
We found that embryos, in which skeleton growth was
arrested by interfering with ectoderm–ECM interactions,
have a reduced number of SM30-expressing PMCs that are
localized along the triradiate spicule rudiments. Accord-
ingly, we found a comparable reduction in the levels of
SM30 mRNA. In agreement, in vitro experiments demon-
strated that withholding serum from micromere cultures
severely depresses SM30 accumulation, but it does not
completely eliminate it (Urry et al., 2000). Furthermore,
short-range signals from different ectodermal territories ap-
pear to regulate the expression of PMC-specific gene prod-
ucts like SM30 that are rate-limiting in skeletal biosynthe-
sis, thereby locally influencing skeletal rod growth (Guss
and Ettensohn, 1997).
A major question is what is the molecular nature of the
signals from ectoderm that regulate skeletal patterning. We
interpreted our results as an effect of decreased concentra-
tions of unknown inductive factor(s) in the blastocoel.
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Therefore, we investigated the levels of expression of univin
and BMP5-7 growth factors. An indication of univin in-
volvement in skeletogenesis came from normal embryo
development, where its expression increases, paralleling
Pl-SM30, at the time of spicule elongation, in contrast to
Pl-BMP5-7. Furthermore, we found that the expression of
the TGF- growth factor gene, univin, shows similar sen-
sitivity as SM30 to Pl-nectin McAb, whereas a related
growth factor, Pl-BMP5-7, did not, raising the possibility
that univin could be the ectoderm-to-PMC signal. The fact
that misexpression of univin in McAb treated embryos can
rescue defects in skeleton elongation and SM30 expression
provide strong support for this notion. These data indicate
that a TGF- signaling pathway is required for skeletal
growth, and a number of experiments discussed above in-
dicate that the ectoderm produces the signal. Whether the
signaling ligand is univin or some closely related factor is
not yet clear, and is being tested with loss-of-function ex-
periments currently in progress. This model predicts that the
PMCs should express a TGF- receptor. Recently, one that
is similar to vertebrate Type I receptor, Alk2, which can
mediate both activin and BMP signals, has been found to be
expressed in ingressed PMCs of S. purpuratus embryos
(L.A., unpublished observations). Whether this receptor me-
diates the skeleton-promoting signal is not yet known.
Unexpectedly, although univin misexpression can rescue
skeletal defects produced by Pl-nectin McAb treatment, it
does not cause any detectable aberrations in development in
the normal embryo. The reason for this is not clear. A
limiting condition could be the proteolytic processing of
univin. This is the case for Vg1, which also does not elicit
phenotypes on injection of mRNA encoding unprocessed
protein, since it yields relatively large amounts of precursor
but rather little mature protein (Thomsen and Melton, 1993;
Dohrmann et al., 1996). Furthermore, it has been suggested
that processing of Vg1 could be highly restricted spatially
(Kessler and Melton, 1995; Dohrmann et al., 1996). Univin
is closely related to Vg1 and, from its nucleotide sequence,
it seems to be proteolytically processed (Stenzel et al.,
1994). Therefore, if situations similar to the above men-
tioned were true for univin, then the lack of a misexpression
phenotype but the presence of a PMC rescue phenotype
could be explained. Alternatively, the univin receptor could
be PMC-specific and spicule growth could be unaffected by
high ligand concentration.
Other signaling pathways are required either directly or
indirectly for skeletogenesis. For example, Ramachandran
et al. (1995) observed that PDGF-BB and TGF- rescued
skeletogenesis, as well as gastrulation in ECM-disrupted
embryos. They also showed that antibodies against human
PDGF-B, TGF-, and their respective receptors inhibited
gut and spicule differentiation and morphogenesis (Ram-
achandran et al., 1995; Govindarajan et al., 1995). Because
perturbations of these signals have effects on multiple cell
types, including the ectoderm, it is possible that the effect
on skeletogenesis is indirect. In contrast, the TGF- path-
way discovered here is different in that it is specific for
spicule growth; our skeleton-defective embryos have nor-
mal gut and ectoderm differentiation (Zito et al., 2000). Our
data support a model in which some ectodermal cells secrete
processed univin or a related factor into the blastocoel
where it signals PMCs to synthesize SM30 and other spicule
matrix proteins required for spicule growth. The ability of
these ectodermal cells to produce the signal depends on
their association with Pl-nectin in the apical ECM.
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